Stay updated on ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s revision/version indicator has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a software release rather than a change to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T06:24:04.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:43:28.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T06:08:37.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:37:57.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    No additions or deletions were detected between the old and new screenshots; the page content appears unchanged.
    Difference
    0.1%
    Check dated 2026-02-25T20:16:13.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    A new revision label 'Revision: v3.4.2' is shown and the older operating-status notice (v3.4.1) has been removed; these are maintenance updates and do not modify the study details.
    Difference
    0.5%
    Check dated 2026-02-11T11:43:03.000Z thumbnail image

Stay in the know with updates to ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page.